nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advance of promising targets and agents against COVID-19 in China
|
Duan, Yongtao |
|
|
25 |
5 |
p. 810-812 |
artikel |
2 |
Contents page 2
|
|
|
|
25 |
5 |
p. ii |
artikel |
3 |
Contents page 1
|
|
|
|
25 |
5 |
p. i |
artikel |
4 |
Déjà vu: Stimulating open drug discovery for SARS-CoV-2
|
Ekins, Sean |
|
|
25 |
5 |
p. 928-941 |
artikel |
5 |
Human accelerated genome regions with value in medical genetics and drug discovery
|
Chu, Xin-Yi |
|
|
25 |
5 |
p. 821-827 |
artikel |
6 |
Impact of the Protein Data Bank on antineoplastic approvals
|
Westbrook, John D. |
|
|
25 |
5 |
p. 837-850 |
artikel |
7 |
Ionic liquids: green and tailor-made solvents in drug delivery
|
Huang, Weizi |
|
|
25 |
5 |
p. 901-908 |
artikel |
8 |
Optimizing skin pharmacotherapy for older patients: the future is at hand but are we ready for it?
|
Hausmann, Christian |
|
|
25 |
5 |
p. 851-861 |
artikel |
9 |
Organotypic cancer tissue models for drug screening: 3D constructs, bioprinting and microfluidic chips
|
Radhakrishnan, Janani |
|
|
25 |
5 |
p. 879-890 |
artikel |
10 |
Prediction of active human dose: learnings from 20 years of Merck KGaA experience, illustrated by case studies
|
Peters, Sheila Annie |
|
|
25 |
5 |
p. 909-919 |
artikel |
11 |
Rediscovery of natural compounds acting via multitarget recognition and noncanonical pharmacodynamical actions
|
Bizzarri, Mariano |
|
|
25 |
5 |
p. 920-927 |
artikel |
12 |
Reversing disease at its core in osteoarthritis
|
Ballester-Beltran, Jose |
|
|
25 |
5 |
p. 807-809 |
artikel |
13 |
Solute carrier proteins and c-Myc: a strong connection in cancer progression
|
Panda, Suman |
|
|
25 |
5 |
p. 891-900 |
artikel |
14 |
Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine
|
Mehta, Darshan |
|
|
25 |
5 |
p. 813-820 |
artikel |
15 |
The production and bioactivity of prodigiosin: quo vadis?
|
Lin, Shian-Ren |
|
|
25 |
5 |
p. 828-836 |
artikel |
16 |
Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities
|
Raval, Nidhi |
|
|
25 |
5 |
p. 862-878 |
artikel |